Farhad Ravandi on Muck Rack

Farhad Ravandi

As seen in: Blood Cancer Journal, Cancer, Nature, Wiley Online Library, Expert Review of Anticancer Therapy, JAMA Oncology, Medscape, Oncology Times, The Lancet, Texas Medical Center, Future Medicine, The ASCO Post and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Farhad

Contact Farhad, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Prognostic impact of ASXL1 mutations in acute myeloid leukemia treated with lower intensity therapy

|
By Jennifer Marvin‐Peek, Courtney DiNardo, Sanam Loghavi, Farhad Ravandi, Gautam Borthakur, Tapan M Kadia, Elias Jabbour, Andrew Dunbar, Guilin Tang, Nicholas Short, Fadi Haddad, Hussein Abbas, Eitan Kugler
| Wiley Online Library
Prognostic impact of ASXL1 mutations in acute myeloid leukemia treated with lower intensity therapy - Marvinā€Peek - 2026 - Cancer - Wiley Online Library
Open in Who Shared Issue with article?

Impact of allogeneic stem cell transplantation in patients with higher risk myelodysplastic syndromes

|
By Alexandre Bazinet, Alex Bataller, Kelly S. Chien, Koji Sasaki, Guillermo Montalban-Bravo, Danielle Hammond, Ian Bouligny, Mahesh Swaminathan, Wei Ying Jen, Eitan Kugler, Rashmi Kanagal-Shamanna, Tapan M Kadia, Gautam Borthakur, Courtney DiNardo, Nicholas Short, Naveen Pemmaraju, Elias Jabbour, Farhad Ravandi, Samuel Urrutia, Georgina Gener-Ricos, Robert Briski, Juan José Rodríguez-Sevilla, Ziyi Li, Richard Champlin, Elizabeth J. Shpall, Amin M. Alousi, Betül Oran, Jeremy Ramdial, Amanda Olson, Sherry Pierce, Julianne Chen, Hagop Kantarjian, Guillermo Garcia-Manero, Uday Popat, Julie Braish
| Nature
Abstract Allogeneic stem cell transplantation (SCT) is a curative treatment in myelodysplastic syndromes (MDS). We performed a retrospective single center study of all patients with newly diagnosed higher risk (HR) MDS (IPSS-R > 3.5 points) between 2000 and 2023. We identified 2045 patients with HR-MDS, of which 427 (21%) underwent SCT.
Open in Who Shared Issue with article?

Immunophenotypic changes following menin inhibition in acute myeloid leukemia

|
By Sanam Loghavi, Trevor Jamison, Alex Bataller, A. Wang, Wei Qing Wang, Guilin Tang, Andres E. Quesada, Alexandre Bazinet, Branko Cuglievan, Courtney DiNardo, Guillermo Montalban-Bravo, Koichi Takahashi, Nicholas Short, Hussein Abbas, Tapan M Kadia, Farhad Ravandi, Elias Jabbour, Gautam Borthakur, Michael Andreeff, L. Jeffrey Medeiros, Hagop Kantarjian, Ghayas C. Issa, Aziz Farhat, Georgina El Hajjar
| Nature
Abstract Menin inhibition leads to an antileukemic effect through hematopoietic differentiation. Treatment with the menin inhibitor revumenib results in clinical remissions in relapsed or refractory (R/R) acute myeloid leukemia (AML) with either rearrangement of lysine methyltransferase 2A (KMT2A) or mutation in nucleophosmin 1 (NPM1), leading to regulatory approval of this drug. However, determinants of response to revumenib have not been fully elucidated.
Open in Who Shared Issue with article?
See all 79 licensed articles (80 Total)

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Farhad

Contact Farhad, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified